Title
Revised Guidelines on Yellow Prescription Pads
Law
Doh Administrative Order No. 2012- 0002
Decision Date
Feb 6, 2012
The Philippine Jurisprudence case provides revised guidelines on the distribution and sale of yellow prescription pads, ensuring accountability, transparency, and availability for authorized health personnel in the management and usage of these pads containing dangerous drugs and/or controlled precursors and essential chemicals.

Questions (DOH ADMINISTRATIVE ORDER NO. 2012- 0002)

All prescriptions for dangerous drugs and/or controlled precursors and essential chemicals issued by authorized practitioners must be written on forms exclusively issued by and obtainable from the Department of Health (DOH). These forms must be made of a special kind of paper and distributed in quantities and with information/data as DOH may require.

The DOH needed to increase accessibility to yellow prescription pads for authorized health personnel and patients, as well as respond to demand—particularly from government physicians—by expanding distribution sites to include all retained hospitals.

To increase access of authorized health personnel to yellow prescription pads and to improve utilization and monitoring of these pads.

All DOH Centers for Health Development (DOH-CHDs) and Hospitals nationwide, as well as partner agencies such as the Dangerous Drugs Board (DDB).

The Special Concerns Technical Cluster (SCTC), DOH through the Dangerous Drug Abuse Prevention and Treatment Program (DDAPTP).

FDA Regulatory Officers of the Centers for Health Development (CHDs) and the designated personnel by the chief of hospital.

At minimum: (i) name of physician/dentist/veterinarian, (ii) S2 license number and residential address, (iii) hospital/clinic/business address, (iv) residential and business telephone numbers.

A maximum of ten (10) prescription pad booklets, at any given time.

Serial numbers must be recorded in the IT database system not later than two (2) weeks from the purchase date.

Used pads shall be returned/surrendered to any distribution site. In compliance with DDB Regulation No. 3, 2003, returned pads must be made available for monitoring by PDEA Regulatory Officers for a minimum of two years and properly kept in the facility storeroom.

Only professionals requiring new purchases shall be allowed to purchase the same number of booklets returned and validated through the IT system.

Pads shall only be released upon presentation of a Payment Receipt.

They must be oriented on: (1) the carbonized feature (no need for carbon paper for second and third copies, and use a separator to avoid penetration/duplication), (2) consequences of unnecessary prescription of dangerous drugs under Section 18 of RA 9165, and (3) consequences of unlawful prescription of dangerous drugs under Section 19 of RA 9165.

Unnecessary prescription (Section 18 of RA 9165): imprisonment from 12 to 20 years and fine of P100,000 to P500,000. Unlawful prescription (Section 19 of RA 9165): life imprisonment to death and fine of P500,000 to P10,000,000.

If only ten percent (10%) of the total number of booklets allocated (threshold stock) is left.

P250 per booklet.

Authorization as representative is allowed only for second-time purchases and onwards, and only after validation of records from the IT system. The representative must present: (i) duly signed authorization from the professional, (ii) duplicate (photocopied) copy of PRC and S2 licenses, and (iii) number of surrendered booklets.

Replacement for lost booklets is allowed only if: (1) a written report is submitted within two weeks detailing circumstances of loss, (2) an affidavit of loss is submitted, and (3) an original or duplicate copy of the police report (blotter) is presented.

The guideline shall be effective immediately.


Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.